GLOBEIMMUNE INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBIM and buy or sell other stocks, ETFs, and their options commission-free!About GBIM
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform.
CEOTimothy C. Rodell, Jr., MD
CEOTimothy C. Rodell, Jr., MD
Employees3
Employees3
HeadquartersLouisville, Colorado
HeadquartersLouisville, Colorado
Founded1995
Founded1995
Employees3
Employees3
GBIM Key Statistics
Market cap575.20
Market cap575.20
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume800.00
Volume800.00
52 Week high$0.0005
52 Week high$0.0005
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, GLOBEIMMUNE INC Common Stock(GBIM) shares are valued at $0.00. The company's market cap stands at 575.2.
On 2026-08-10, GLOBEIMMUNE INC Common Stock(GBIM) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for GLOBEIMMUNE INC Common Stock(GBIM) stock has reached 800.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.